3,4-Diaminopyridine
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for 3,4-Diaminopyridine, covering 2015-03-25 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism [Phase 2, Phase 3]